Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
How do you approach the use of Cequa in eyes with severe corneal thinning from a prior, healed corneal ulcer?
Related Questions
How does CTAK compare to conventional keratoplasty techniques (PK/ALK) in patients with corneal ectasia?
How do you predict which patients are most likely to have a positive response to Oxervate?
How do you decide who would be a candidate for a prosthetic iris implant and what pre-op evaluation or testing do you do?
How do you approach IOL calculations and selection in patients with keratoconus based on disease severity?
In patients with corneal edema and a glaucoma drainage tube placed in the AC, under what circumstances would you consider repositioning the tube in the sulcus first versus proceeding directly with endothelial keratoplasty alone?
How would you approach the management of a patient presenting with bilateral central corneal perforations following treatment with Ipilimumab/Nivolumab?
In what clinical scenarios do you incorporate topical insulin drops to treat persistent epithelial defects?
What supportive care measures do you prioritize to manage or prevent toxicity in patients receiving Dato-DXd?
In cases of failed endothelial keratoplasty with concurrent cataract, do you favor repeat keratoplasty plus lens extraction in the same setting or sequential surgeries?
How should newer pharmacologic agents be integrated into treatment protocols to maximize symptomatic relief while addressing underlying causes such as inflammation and meibomian gland dysfunction in patients with dry eye disease?
